Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Interactive Journal of Medical Research

Date Submitted: Jul 4, 2024
Date Accepted: Dec 19, 2024

The final, peer-reviewed published version of this preprint can be found here:

Therapeutic Guidelines for the Self-Management of Major Depressive Disorder: Scoping Review

do Perpétuo Socorro de Sousa Nóbrega Sr M Sr, de Campos Tiburcio P Sr, Maria Marcheti Sr P Sr, Miori Pascon Sr D Sr, Montebello Junior Sr MA Sr, Alzete de Lima Sr M Sr, Neves da Nova Fernandes Sr CS Sr, Samarina Vilaça de Brito Santos C Sr

Therapeutic Guidelines for the Self-Management of Major Depressive Disorder: Scoping Review

Interact J Med Res 2025;14:e63959

DOI: 10.2196/63959

PMID: 40053745

PMCID: 11926446

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Therapeutic Guidelines for self-management of major depressive disorder: scoping review

  • Maria do Perpétuo Socorro de Sousa Nóbrega Sr Sr; 
  • Priscila de Campos Tiburcio Sr; 
  • Priscila Maria Marcheti Sr Sr; 
  • Daniela Miori Pascon Sr Sr; 
  • Marco Antônio Montebello Junior Sr Sr; 
  • Maria Alzete de Lima Sr Sr; 
  • Carla Sílvia Neves da Nova Fernandes Sr Sr; 
  • Célia Samarina Vilaça de Brito Santos Sr

ABSTRACT

Background:

Abstract

Background:

Major Depressive Disorder affects millions of people globally, causing significant impacts on individuals' health and functionality. Given the difficulty of treatment adherence due to adverse effects, and considering the growing adoption of technologies, the Self-Management-in-Mental Health project emerged. This project aims to promote patient autonomy through the development of a self-management support app for Major Depressive Disorder, providing evidence-based therapeutic guidance.

Objective:

Objective:

To identify therapeutic guidelines for the symptoms of Major Depressive Disorder in scientific production.

Methods:

Method: a scoping review, following the recommendations of the JBI, conducted on 18 databases and 4 secondary information sources. The studies were collected between March and July 2022 and updated in June 2023.

Results:

Results:

63 studies published between 2011 and 2023 were included. Among the therapeutic guidelines identified, mapped and categorized, the following stood out: adoption of healthy habits (53.25%), integrative and complementary practices (52.11%), psychotherapy (30.99%), consultation with a health professional (21.13%), relaxation techniques (16.09%), pharmacological therapy (14.01%), leisure/pleasurable activities (9.86%).

Conclusions:

Conclusion: therapeutic guidance has contributed to promoting self-management and is an important resource for health professionals in playing the role of facilitator in developing knowledge and skills for possible complications of Major Depressive Disorder.


 Citation

Please cite as:

do Perpétuo Socorro de Sousa Nóbrega Sr M Sr, de Campos Tiburcio P Sr, Maria Marcheti Sr P Sr, Miori Pascon Sr D Sr, Montebello Junior Sr MA Sr, Alzete de Lima Sr M Sr, Neves da Nova Fernandes Sr CS Sr, Samarina Vilaça de Brito Santos C Sr

Therapeutic Guidelines for the Self-Management of Major Depressive Disorder: Scoping Review

Interact J Med Res 2025;14:e63959

DOI: 10.2196/63959

PMID: 40053745

PMCID: 11926446

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.